<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.onhealthcare.tech/p/a-public-equity-diligence-walk-on</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-27T21:40:12+00:00</news:publication_date><news:title>A Public Equity Diligence Walk on HIMS After the GLP-1 Reset, the Eucalyptus Buy, and the Peptide Catalyst: What the FY2025 10-K, Novo Settlement, and LillyDirect Routing Tell You Heading Into Q1 2026</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/where-commercial-vbc-actually-lives</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-26T11:40:54+00:00</news:publication_date><news:title>Where Commercial VBC Actually Lives Now</news:title></news:news></url></urlset>